Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2Theresa Klemm, David Komander, Zhong Yan Gan et al.|The EMBO Journal|2020Cited by 499
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro InhibitorsDale J. Calleja, David Komander, Nathan W. Kuchel et al.|Frontiers in Chemistry|2022Cited by 48
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVIDStefanie M. Bader, David Komander, Dale J. Calleja et al.|Nature Communications|2025Cited by 35
Mechanism and inhibition of SARS-CoV-2 PLproTheresa Klemm, David Komander, Gregor Ebert et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 15
A novel PLpro inhibitor scaffold that protects mice from Long-COVIDDavid Komander, Guillaume Lessène, Marcel Doerflinger et al.|Research Square|2024Cited by 1